HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roy H Larsen Selected Research

ibritumomab tiuxetan (Zevalin)

3/2013Biodistribution and dosimetry of (177)Lu-tetulomab, a new radioimmunoconjugate for treatment of non-Hodgkin lymphoma.
9/2008Relative biologic effects of low-dose-rate alpha-emitting 227Th-rituximab and beta-emitting 90Y-tiuexetan-ibritumomab versus external beam X-radiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roy H Larsen Research Topics

Disease

16Neoplasms (Cancer)
01/2021 - 01/2005
6Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2018 - 02/2006
6Lymphoma (Lymphomas)
01/2010 - 02/2006
5Neoplasm Metastasis (Metastasis)
01/2020 - 06/2002
3Prostatic Neoplasms (Prostate Cancer)
01/2020 - 06/2005
2Osteosarcoma (Osteogenic Sarcoma)
01/2016 - 01/2005
2B-Cell Lymphoma (Lymphoma, B Cell)
07/2014 - 01/2013
1Burkitt Lymphoma (Burkitt's Lymphoma)
10/2018
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2018
1Ovarian Neoplasms (Ovarian Cancer)
04/2018
1Carcinoma (Carcinomatosis)
04/2018
1Neoplasm Micrometastasis
04/2018
1Peritoneal Neoplasms
01/2018
1Circulating Neoplastic Cells
01/2016
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2014
1Body Weight (Weight, Body)
10/2006

Drug/Important Bio-Agent (IBA)

12Radioisotopes (Radionuclides)IBA
01/2021 - 06/2002
10Immunoconjugates (Immunoconjugate)IBA
10/2018 - 02/2006
7AntigensIBA
01/2020 - 01/2005
5Rituximab (Mabthera)FDA Link
10/2018 - 08/2007
3Calcium Carbonate (Limestone)FDA Link
01/2021 - 01/2018
3RadiopharmaceuticalsIBA
01/2020 - 01/2005
3AntibodiesIBA
01/2016 - 01/2005
3Monoclonal AntibodiesIBA
07/2014 - 01/2005
2Therapeutic UsesIBA
04/2018 - 06/2002
2Immunoglobulin G (IgG)IBA
01/2016 - 01/2005
2tetulomab tetraxetan lu-177IBA
01/2015 - 01/2014
2ibritumomab tiuxetan (Zevalin)FDA Link
03/2013 - 09/2008
1SuspensionsIBA
01/2021
1Lead-212IBA
12/2020
1IsotopesIBA
01/2020
1LigandsIBA
01/2020
1SolutionsIBA
01/2020
1Cetuximab (Erbitux)FDA Link
01/2016
1Saline SolutionIBA
01/2015
1Lutetium-177IBA
07/2014
1Proteins (Proteins, Gene)FDA Link
03/2013
1EpitopesIBA
01/2013
1thorium-227-DOTA-rituximabIBA
11/2009
1AcidsIBA
11/2009
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
11/2009
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
09/2008
1Biological ProductsIBA
09/2008
1Thorium-227IBA
09/2007
1Hormones (Hormone)IBA
10/2006
1Liposomes (Liposome)IBA
07/2006
1Radium-223IBA
06/2005
1splenotritin (TP3)IBA
01/2005
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2005
1thymostimulinIBA
01/2005

Therapy/Procedure

11Therapeutics
01/2021 - 09/2007
6Radioimmunotherapy
01/2016 - 02/2006
1Precision Medicine
01/2020
1Castration
01/2020
1Drug Therapy (Chemotherapy)
04/2018
1Injections
10/2006
1Radiotherapy
10/2006